Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 2.1 | - |
NAV | ₹29.90 | - |
Fund Started | 04 Dec 2015 | - |
Fund Size | ₹1338.85 Cr | - |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | - |
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.1
-
NAV
₹29.90
-
Fund Started
04 Dec 2015
-
Fund Size
₹1338.85 Cr
-
Exit Load
Exit load of 0.25% if redeemed within 30 days.
-
1 Year | -5.26% | - |
3 Year | 21.73% | - |
5 Year | 14.73% | - |
1 Year
-5.26%
-
3 Year
21.73%
-
5 Year
14.73%
-
Equity | 95.00% | - |
Cash | 5.00% | - |
Equity
95.00%
-
Cash
5.00%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 7.75% |
Max Healthcare Institute Ltd. | 5.65% |
Healthcare Global Enterprises Ltd. | 5.13% |
Abbott India Ltd. | 5.04% |
Apollo Hospitals Enterprise Ltd. | 4.85% |
Ipca Laboratories Ltd. | 3.99% |
Cipla Ltd. | 3.96% |
Rainbow Children's Medicare Ltd. | 3.78% |
Lupin Ltd. | 3.57% |
Ajanta Pharma Ltd. | 3.45% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | - |
Launch Date | 04 Dec 2015 | - |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
-
Launch Date
04 Dec 2015
-